department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Tofacitinib Citrate · catalysts · pharmadog

← back to Tofacitinib Citrate

Catalysts for Tofacitinib Citrate

32 tracked

TOFACITINIB CITRATE — FDA approval

tofacitinib citrate ER

XELJANZ (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ XR (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

TOFACITINIB CITRATE — FDA approval

tofacitinib citrate ER

TOFACITINIB CITRATE — FDA approval

tofacitinib citrate ER

TOFACITINIB CITRATE — FDA approval

tofacitinib citrate ER

TOFACITINIB CITRATE — FDA approval

tofacitinib citrate ER

TOFACITINIB CITRATE — FDA approval

tofacitinib citrate ER

TOFACITINIB CITRATE — FDA approval

tofacitinib citrate ER

XELJANZ (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

TOFACITINIB CITRATE — FDA approval

tofacitinib citrate ER

XELJANZ (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ XR (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ XR (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ XR (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ XR (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ XR (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

TOFACITINIB CITRATE — FDA approval

tofacitinib citrate ER

XELJANZ (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ XR (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ XR (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ XR (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ XR (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ XR (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ XR (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

XELJANZ XR (TOFACITINIB CITRATE) — FDA approval

tofacitinib citrate ER

← prevpage 1 of 2next →

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%

$SIGY0.04000.00%

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%

$PFE24.25+0.83%